Women’s Health
8 min read
8 May 2026
Perimenopause, Oestrogen and Blood Sugar: The Connection Most Women Miss
The hormonal shift that drives perimenopausal symptoms also directly disrupts insulin sensitivity. The two processes share the same driver.
Jon Bell
Metabolic Health Specialist · Leamington Spa
For many women, perimenopause announces itself through the familiar: disrupted sleep, hot flushes, mood shifts, changes in cycle length. What is less commonly discussed, and far more consequential for long-term health, is what is happening to metabolic function at the same time. The oestrogen decline that drives perimenopausal symptoms also directly disrupts insulin sensitivity. The two processes are not coincidental. They share the same hormonal driver.
Oestrogen and Insulin Sensitivity
Oestrogen acts on insulin receptors throughout the body, in muscle tissue, adipose tissue, and the liver. It increases the expression of GLUT4 transporters (the proteins that move glucose into cells in response to insulin), enhances insulin receptor sensitivity, and reduces hepatic glucose production. In practical terms, adequate oestrogen levels help your body manage blood sugar efficiently and with relatively little insulin.
As oestrogen declines during perimenopause, a process that typically begins in the early to mid-40s and continues through to the final menstrual period, insulin sensitivity decreases in parallel. The same meal that your body handled easily at 38 produces a larger blood sugar spike and requires more insulin to clear at 47. This is not a failure of willpower or discipline. It is a measurable hormonal change with a measurable metabolic consequence.
Perimenopause onset
Average age: 47
Metabolic changes, including declining insulin sensitivity, typically precede the final menstrual period by 5 to 8 years. Most go unaddressed in standard GP care.
What Changes in the Blood Work
In Jon Bell’s client group, which is heavily weighted toward perimenopausal and postmenopausal women, the pattern is consistent across cases:
- Fasting insulin rises, often while fasting glucose remains technically normal
- Post-meal glucose spikes become larger and take longer to resolve
- Triglycerides rise, frequently alongside LDL cholesterol
- HbA1c inches upward year on year, even with no meaningful change in eating habits
- Visceral fat increases, particularly around the abdomen and at the waist
These changes do not typically trigger intervention in a standard GP consultation, because the individual markers remain within their reference ranges. Taken together, however, they describe a coherent picture of declining metabolic function that, if unaddressed, progresses predictably toward prediabetes, elevated cardiovascular risk, and worsening hormonal symptoms.
"You can have a 'normal' blood test and a metabolic picture that is clearly deteriorating. The reference ranges were not designed to catch this. A precision framework was."
The Continuous Glucose Monitor Picture
CGM use in perimenopausal women frequently reveals two patterns that blood tests miss entirely: significant post-meal glucose variability, and elevated fasting glucose in the early morning, even when the HbA1c is unremarkable. The morning elevation is driven by the dawn phenomenon (cortisol-driven hepatic glucose release) compounded by declining oestrogen’s reduced buffering effect on cortisol. For many women, this is the first clear signal that metabolic function has shifted. It shows on a 14-day CGM trace long before any standard blood result changes.
What the Six Pillar Method Addresses
Jon’s programme does not treat perimenopause. It addresses the metabolic consequences of the hormonal changes that perimenopause produces, which are distinct and targetable. The six pillars work in combination in a perimenopausal context: targeted nutrition reduces post-meal glucose load while maintaining adequate protein to offset sarcopenia risk; structured movement enhances GLUT4 expression, partially compensating for reduced oestrogen-driven insulin sensitivity; sleep optimisation reduces cortisol and the morning glucose elevation; stress management further reduces cortisol-driven insulin resistance.
The blood work at 12 weeks typically shows HbA1c reduced by 3 to 6 mmol/mol, fasting insulin reduced, triglycerides falling, and improved lipid ratios. These changes are not the result of a diet plan imposed on top of a hormonal reality. They are the result of addressing the correct levers, in the correct order, guided by what the blood work shows at the start of the programme.
Frequently Asked
Oestrogen and Insulin Sensitivity
Oestrogen acts on insulin receptors throughout the body, in muscle tissue, adipose tissue, and the liver. It increases the expression of GLUT4 transporters (the proteins that move glucose into cells in response to insulin), enhances insulin receptor sensitivity, and reduces hepatic glucose production. In practical terms, adequate oestrogen levels help your body manage blood sugar efficiently and with relatively little insulin.
What Changes in the Blood Work
In Jon Bell’s client group, which is heavily weighted toward perimenopausal and postmenopausal women, the pattern is consistent across cases:
The Continuous Glucose Monitor Picture
CGM use in perimenopausal women frequently reveals two patterns that blood tests miss entirely: significant post-meal glucose variability, and elevated fasting glucose in the early morning, even when the HbA1c is unremarkable. The morning elevation is driven by the dawn phenomenon (cortisol-driven hepatic glucose release) compounded by declining oestrogen’s reduced buffering effect on cortisol. For many women, this is the first clear signal that metabolic function has shifted. It shows on a 14-day CGM trace long before any standard blood result changes.
What the Six Pillar Method Addresses
Jon’s programme does not treat perimenopause. It addresses the metabolic consequences of the hormonal changes that perimenopause produces, which are distinct and targetable. The six pillars work in combination in a perimenopausal context: targeted nutrition reduces post-meal glucose load while maintaining adequate protein to offset sarcopenia risk; structured movement enhances GLUT4 expression, partially compensating for reduced oestrogen-driven insulin sensitivity; sleep optimisation reduces cortisol and the morning glucose elevation; stress management further reduces cortisol-driven insulin resistance.